ECSP17073558A - Sistema de suministro de insulina sensible a la glucosa usando nanocompuestos sensibles a la hipoxia - Google Patents
Sistema de suministro de insulina sensible a la glucosa usando nanocompuestos sensibles a la hipoxiaInfo
- Publication number
- ECSP17073558A ECSP17073558A ECIEPI201773558A ECPI201773558A ECSP17073558A EC SP17073558 A ECSP17073558 A EC SP17073558A EC IEPI201773558 A ECIEPI201773558 A EC IEPI201773558A EC PI201773558 A ECPI201773558 A EC PI201773558A EC SP17073558 A ECSP17073558 A EC SP17073558A
- Authority
- EC
- Ecuador
- Prior art keywords
- sensitive
- delivery system
- hypoxia
- insulin
- glucose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/03004—Glucose oxidase (1.1.3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
Abstract
Se describe un sistema de suministro de insulina de bucle cerrado. De forma más particular, el sistema de suministro de insulina que ahora se desvela pude comprender vesículas sensibles a glucosa que liberan insulina en respuesta a la hipoxia desencadenada por la reducción enzimática de glucosa. Además o como alternativa a la insulina, el sistema de suministro puede liberar otros agentes de tratamiento de la diabetes, tales como agentes de tratamiento de la diabetes no basados en insulina. Las vesículas pueden prepararse a partir de un polímero sensible a la hipoxia, tal como un ácido hialurónico sensible a la hipoxia (AH-SH). El AH-SH puede comprender grupos hidrofóbicos que pueden reducirse en entornos hipóxicos para formar grupos hidrófilos. Las vesículas pueden cargarse en microagujas y parches de matriz de microagujas para su uso en el tratamiento de la diabetes o para regular de otro modo los niveles de glucosa en sangre en sujetos que necesiten tal tratamiento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562150622P | 2015-04-21 | 2015-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP17073558A true ECSP17073558A (es) | 2018-05-31 |
Family
ID=57144247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECIEPI201773558A ECSP17073558A (es) | 2015-04-21 | 2017-11-06 | Sistema de suministro de insulina sensible a la glucosa usando nanocompuestos sensibles a la hipoxia |
Country Status (22)
Country | Link |
---|---|
US (2) | US11191815B2 (es) |
EP (2) | EP3285750B1 (es) |
JP (1) | JP6856546B2 (es) |
KR (1) | KR102624501B1 (es) |
CN (2) | CN107530296B (es) |
AU (2) | AU2016252738B2 (es) |
BR (1) | BR112017022535A2 (es) |
CA (1) | CA2983289C (es) |
CL (1) | CL2017002652A1 (es) |
CO (1) | CO2017011422A2 (es) |
DO (1) | DOP2017000239A (es) |
EC (1) | ECSP17073558A (es) |
HK (1) | HK1245105A1 (es) |
IL (1) | IL255155A0 (es) |
MA (1) | MA54623A (es) |
MX (1) | MX2017013337A (es) |
PE (1) | PE20180325A1 (es) |
PH (1) | PH12017501910A1 (es) |
RU (1) | RU2719584C2 (es) |
SG (1) | SG11201708509YA (es) |
TN (1) | TN2017000439A1 (es) |
WO (1) | WO2016172320A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2719584C2 (ru) | 2015-04-21 | 2020-04-21 | Норт Каролина Стейт Юниверсити | Глюкозочувствительная система доставки инсулина с использованием чувствительных к гипоксии нанокомпозитов |
EP3416621B1 (en) | 2016-02-19 | 2023-12-20 | North Carolina State University | Physiologically responsive microneedle delivery systems |
US11351230B2 (en) | 2016-11-07 | 2022-06-07 | North Carolina State University | Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery |
US11331277B2 (en) | 2016-12-05 | 2022-05-17 | North Carolina State University | H2O2-responsive nanoparticles and uses thereof |
US11697007B2 (en) | 2016-12-05 | 2023-07-11 | North Carolina State University | Core-shell microneedle devices and uses thereof |
US11850285B2 (en) | 2017-03-07 | 2023-12-26 | North Carolina State University | Insulin-responsive glucagon delivery patch |
EP3634470A4 (en) | 2017-06-02 | 2021-03-10 | North Carolina State University | GLUCOSE-SENSITIVE COMPOSITIONS FOR DRUG DISPENSING |
JP6482604B2 (ja) * | 2017-06-22 | 2019-03-13 | 教裕 南郷 | 外皮内溶解型ニードル及びニードル装置 |
US11389405B2 (en) | 2017-09-18 | 2022-07-19 | North Carolina State University | Artificial beta cells and methods of use thereof |
WO2019075052A1 (en) * | 2017-10-10 | 2019-04-18 | North Carolina State University | INSULIN MODIFIED BY GLUCOSE TRANSPORTER INHIBITOR FOR GLUCOSE SENSITIVE INSULIN ADMINISTRATION |
CN111629746B (zh) | 2017-11-21 | 2024-04-16 | 北卡罗来纳州立大学 | 具有超快响应的用于葡萄糖触发胰岛素递送的电荷可切换聚合物储库 |
CN108484848A (zh) * | 2018-02-27 | 2018-09-04 | 同济大学 | 一种缺氧响应的聚合物纳米胶束及其制备方法 |
CN108440684A (zh) * | 2018-03-22 | 2018-08-24 | 华侨大学 | 一种NI-Cys-Alg自组装纳米载体及其制备方法和应用 |
CN108395489A (zh) * | 2018-03-22 | 2018-08-14 | 华侨大学 | 一种2-硝基咪唑-半胱氨酸-海藻酸盐材料及其制备方法 |
EP3765029A4 (en) * | 2018-04-13 | 2021-12-08 | North Carolina State University | ROS-RESPONSIVE MICRON NEEDLE PLASTER FOR ACNE VULGARIS TREATMENT |
WO2019200063A1 (en) * | 2018-04-13 | 2019-10-17 | North Carolina State University | Use of microneedle patch to promote hair growth |
CN109464657A (zh) * | 2018-11-26 | 2019-03-15 | 常州工程职业技术学院 | 一种嵌段共聚物载胰岛素控制释放的方法 |
CN109568567A (zh) * | 2019-01-15 | 2019-04-05 | 武汉德丽福生物科技有限公司 | 一种微针减肥贴片及其制备方法 |
CN109771659A (zh) * | 2019-02-25 | 2019-05-21 | 天津大学 | 一种乏氧响应性纳米药物载体及其制备方法和应用 |
CN110652494B (zh) * | 2019-10-21 | 2021-09-28 | 南通大学 | 一种低氧响应聚氨基酸-peg立构载药胶束及其制备方法 |
CN110841065A (zh) * | 2019-12-05 | 2020-02-28 | 福州大学 | 一种pH/低氧双响应释药协同光动力治疗的纳米复合物及其制备方法 |
CN115317437B (zh) * | 2021-05-11 | 2023-09-08 | 中国科学院上海硅酸盐研究所 | 一种基于胆红素纳米材料的胰岛素递送微针及其制备方法 |
CN114376569B (zh) * | 2022-01-19 | 2023-10-13 | 浙江大学 | 用于救治低血糖的载胰高血糖素可穿戴设备 |
CN114432243B (zh) * | 2022-01-20 | 2023-08-29 | 华南师范大学 | 一种响应pH和葡萄糖的纳米载体及其应用 |
CN115120552B (zh) * | 2022-06-22 | 2024-06-04 | 华中科技大学 | 一种微环境响应释药的多肽载药微针贴片、制备及应用 |
CN115531309B (zh) * | 2022-09-29 | 2023-08-22 | 中国药科大学 | 一种肝靶向聚合物胶束递药系统及其制备方法和应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9415810D0 (en) * | 1994-08-04 | 1994-09-28 | Jerrow Mohammad A Z | Composition |
US8465468B1 (en) * | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
EP1389090A2 (en) * | 2001-04-26 | 2004-02-18 | Board of Regents, The University of Texas System | Diagnostic imaging compositions, their methods of synthesis and use |
GB0116860D0 (en) | 2001-07-10 | 2001-09-05 | Univ Montfort | Gel compositions |
US20030135201A1 (en) * | 2001-09-28 | 2003-07-17 | Gonnelli Robert R. | Microneedle with membrane |
US6960617B2 (en) | 2002-04-22 | 2005-11-01 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
JP4185423B2 (ja) | 2003-09-09 | 2008-11-26 | 日本電信電話株式会社 | 電気化学バイオセンサの製造方法 |
US20080102114A1 (en) | 2004-04-23 | 2008-05-01 | Panduranga Rao Koritala | Microparticles and Nanoparticles for the Transmucosal Delivery of Therapeutic and Diagnostic Agents |
WO2007012114A1 (en) | 2005-07-25 | 2007-02-01 | Nanotechnology Victoria Pty Ltd | Microarray device |
WO2007075388A2 (en) * | 2005-12-15 | 2007-07-05 | X-Cell Medical Incorporated | Methods of locally treating and preventing cardiac disorders |
WO2008011625A2 (en) * | 2006-07-21 | 2008-01-24 | Georgia Tech Researh Corporation | Microneedle devices and methods of drug delivery or fluid withdrawal |
CN101125086A (zh) * | 2006-08-18 | 2008-02-20 | 刘胜 | 闭环自动控制胰岛素注射系统 |
AU2009216216B2 (en) * | 2008-02-22 | 2013-11-07 | Toray Industries, Inc. | Microparticles and pharmaceutical compositions thereof |
US7775357B2 (en) | 2008-04-14 | 2010-08-17 | Asp Rights Management Pty Limited | Syringe disposal device |
KR20100037389A (ko) * | 2008-10-01 | 2010-04-09 | 연세대학교 산학협력단 | 다중 약물방출조절이 가능한 솔리드 마이크로구조체 및 이의 제조방법 |
US9320878B2 (en) * | 2008-10-07 | 2016-04-26 | Tuo Jin | Phase-transition polymeric microneedles |
KR20140054404A (ko) | 2009-01-28 | 2014-05-08 | 스마트쎌스, 인크. | 결정질 인슐린-접합체 |
US20120046651A1 (en) | 2009-04-17 | 2012-02-23 | Uwe Beyer | Medical device for glucose monitoring or regulation |
CN102039000B (zh) * | 2009-10-20 | 2015-08-26 | 苏州纳通生物纳米技术有限公司 | 一种透皮给药试剂盒 |
WO2012050179A1 (ja) | 2010-10-14 | 2012-04-19 | シャープ株式会社 | 液晶表示装置の製造方法 |
GB201101429D0 (en) * | 2011-01-27 | 2011-03-16 | Biocompatibles Uk Ltd | Drug delivery system |
CA2902762A1 (en) | 2012-02-17 | 2013-08-22 | Massachusetts Institute Of Technology | Glucose-responsive microgels for closed loop insulin delivery |
MX2015015079A (es) * | 2013-04-30 | 2016-07-05 | Massachusetts Inst Technology | Geles de nano-red inyectables para tratamiento de diabetes. |
KR102133889B1 (ko) * | 2013-06-28 | 2020-07-14 | 엘지이노텍 주식회사 | 회로기판 및 상기 회로기판을 포함하는 조명장치 |
CN104353062A (zh) * | 2014-11-21 | 2015-02-18 | 中国人民解放军南京军区福州总医院 | 一种胰岛素口服纳米制剂及其制备方法 |
RU2719584C2 (ru) | 2015-04-21 | 2020-04-21 | Норт Каролина Стейт Юниверсити | Глюкозочувствительная система доставки инсулина с использованием чувствительных к гипоксии нанокомпозитов |
US11141486B2 (en) | 2015-10-23 | 2021-10-12 | National University Corporation Tokyo Medical And Dental University | Drug delivery device |
EP3416621B1 (en) | 2016-02-19 | 2023-12-20 | North Carolina State University | Physiologically responsive microneedle delivery systems |
US11351230B2 (en) | 2016-11-07 | 2022-06-07 | North Carolina State University | Patch loaded with dual-sensitive vesicles for enhanced glucose-responsive insulin delivery |
-
2016
- 2016-04-21 RU RU2017139931A patent/RU2719584C2/ru active
- 2016-04-21 BR BR112017022535A patent/BR112017022535A2/pt not_active IP Right Cessation
- 2016-04-21 EP EP16783841.6A patent/EP3285750B1/en active Active
- 2016-04-21 JP JP2017555709A patent/JP6856546B2/ja active Active
- 2016-04-21 KR KR1020177033592A patent/KR102624501B1/ko active IP Right Grant
- 2016-04-21 CA CA2983289A patent/CA2983289C/en active Active
- 2016-04-21 CN CN201680023377.6A patent/CN107530296B/zh active Active
- 2016-04-21 TN TNP/2017/000439A patent/TN2017000439A1/en unknown
- 2016-04-21 CN CN202110614275.4A patent/CN113350489A/zh active Pending
- 2016-04-21 SG SG11201708509YA patent/SG11201708509YA/en unknown
- 2016-04-21 AU AU2016252738A patent/AU2016252738B2/en active Active
- 2016-04-21 PE PE2017002202A patent/PE20180325A1/es not_active Application Discontinuation
- 2016-04-21 WO PCT/US2016/028605 patent/WO2016172320A1/en active Application Filing
- 2016-04-21 US US15/567,532 patent/US11191815B2/en active Active
- 2016-04-21 MX MX2017013337A patent/MX2017013337A/es unknown
- 2016-04-21 EP EP20202740.5A patent/EP3795143A1/en not_active Withdrawn
- 2016-04-21 MA MA054623A patent/MA54623A/fr unknown
-
2017
- 2017-10-17 DO DO2017000239A patent/DOP2017000239A/es unknown
- 2017-10-19 CL CL2017002652A patent/CL2017002652A1/es unknown
- 2017-10-19 IL IL255155A patent/IL255155A0/en unknown
- 2017-10-19 PH PH12017501910A patent/PH12017501910A1/en unknown
- 2017-11-06 EC ECIEPI201773558A patent/ECSP17073558A/es unknown
- 2017-11-07 CO CONC2017/0011422A patent/CO2017011422A2/es unknown
-
2018
- 2018-04-09 HK HK18104568.4A patent/HK1245105A1/zh unknown
-
2021
- 2021-06-17 AU AU2021204048A patent/AU2021204048A1/en not_active Abandoned
- 2021-12-03 US US17/542,021 patent/US20220160841A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP17073558A (es) | Sistema de suministro de insulina sensible a la glucosa usando nanocompuestos sensibles a la hipoxia | |
BR112016016290A2 (pt) | Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina | |
BR112015005940A2 (pt) | processo para a preparação de nanopartículas terapêuticas | |
CL2015002680A1 (es) | Composición farmaceutica que comprende un activador de ampk y un agente serotoninérgico y método para usar los mismos | |
TW201613588A (en) | Ophthalmic composition | |
BR112018003882A2 (pt) | material auxiliar para proporcionar eluição de fármaco de vasos | |
BR112014013151A2 (pt) | dispositivo de microagulhas incluindo um agente terapêutico peptídeo e um aminoácido, métodos para produzir e usar o dispositivo | |
AR069704A1 (es) | Sistema de administracion de rnai de interferencia y usos del mismo | |
BR112013003160A2 (pt) | tratamento de diabetes com células precursoras endócrinas pancráticas | |
BR112013024973A2 (pt) | prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2 | |
PH12015501931A1 (en) | Treatment of diabetes mellitus by long-acting formulations of insulins | |
BR112013027010A2 (pt) | método de produzir substâncias com gás supersaturado, dispositivo para sua entrega trasdérmica, e seus usos | |
PE20191836A1 (es) | Compuesto de insulina acilada | |
EA201691420A1 (ru) | Композиции енолазы 1 (eno1) и их применение | |
SG10201906172XA (en) | Regulation of glucose metabolism using anti-cgrp antibodies | |
CR20140473A (es) | Compuestos de pirazol como inhibidores de sglt1 | |
TN2015000498A1 (en) | Modified release formulation | |
MX2016001607A (es) | Microesferas de entecavir y composicion farmaceutica para administracion parenteral que contiene las mismas. | |
BR112013027006A2 (pt) | método de produzir substâncias com gás supersaturado, dispositivo de distribuição transdérmica do mesmo | |
BR112019001082A2 (pt) | gel intestinal de levodopa e carbidopa e métodos de uso | |
BR112018000525A2 (pt) | concentrado contendo alprostadil | |
AR081049A1 (es) | Medicamento oftalmico para el tratamiento de la hipermetropia | |
EA202090988A1 (ru) | Способы лечения синдрома фелан-макдермид с помощью дибензодиазепинонов фарнезила | |
ES2466065B1 (es) | Modificación de poliuretano con polímeros sensibles a estímulos biocompatibles para carga y cesión de fármacos | |
TH172399A (th) | การบำบัดโรคเบาหวานด้วยสูตรผสมอินซูลินที่ออกฤทธิ์นาน |